AMGN vs SRTAW · P/E 24, rev $10.05B vs rev $248.7M
Amgen Inc (AMGN) versus Strata Critical Medical, Inc. (SRTAW) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported SRTAW revenue for 2024-12-31 was $248.7M. Net income was -$27.3M. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. SRTAW currently screens at market cap $0.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. SRTAW currently screens at market cap $0.
Not investment advice. Open the AMGN and SRTAW stock pages for the full models.
Not investment advice.